Swisscanto (CH) Index Equity Fund World ex CH NT USD

Reference Data

ISIN CH1417302093
Valor Number 141730209
Bloomberg Global ID
Fund Name Swisscanto (CH) Index Equity Fund World ex CH NT USD
Fund Provider Swisscanto Fondsleitung AG Zurich
E-Mail: fonds@swisscanto.ch
Fund Provider Swisscanto Fondsleitung AG
Representative in Switzerland
Distributor(s) Schweizerische Kantonalbanken
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Switzerland
Issuing Condition The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** The investment objective of the fund is to replicate the risk and return characteristics of the reference index.The fund primarily invests directly and indirectly in shares and other equity securities that are contained in the reference index.The use of derivatives equates to neither leveraging nor short selling with regard to the fund assets.
Peculiarities

Fund Prices

Current Price * 91.38 USD 17.04.2025
Previous Price * 91.23 USD 16.04.2025
52 Week High * 100.00 USD 28.02.2025
52 Week Low * 85.59 USD 08.04.2025
NAV * 91.38 USD 17.04.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 932,080,517
Unit/Share Assets *** 9,548
Trading Information SIX

Performance

YTD Performance - -
YTD Performance (in CHF) - -
1 month -5.92% 17.03.2025
17.04.2025
3 months -8.62% 28.02.2025
17.04.2025
6 months - -
1 year - -
2 years - -
3 years - -
5 years - -

Tax Data

Equity Participation Rate in % 94.90
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

iShares MSCI USA ETF USD Acc 26.69%
Xtrackers MSCI USA ETF 1C 26.69%
UBS ETF MSCI USA (USD) A-acc 9.87%
Amundi MSCI USA ETF Acc 9.29%
E-mini S&P 500 Future June 25 0.69%
SAP SE 0.41%
ASML Holding NV 0.39%
AstraZeneca PLC 0.35%
Novo Nordisk AS Class B 0.33%
Shell PLC 0.32%
Last data update 31.03.2025

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee *** 0.00%
Ongoing Charges *** 0.05%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)